REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 50 filers reported holding REDHILL BIOPHARMA LTD in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | -100.0% | 330 | -88.7% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 2,915 | +39.1% | 0.00% | – |
| Q2 2022 | $2,000 | -86.7% | 2,095 | -65.0% | 0.00% | – |
| Q1 2022 | $15,000 | +25.0% | 5,983 | +31.5% | 0.00% | – |
| Q4 2021 | $12,000 | -94.3% | 4,549 | -90.0% | 0.00% | – |
| Q3 2021 | $209,000 | +1507.7% | 45,658 | +2361.3% | 0.00% | – |
| Q2 2021 | $13,000 | -97.0% | 1,855 | -96.9% | 0.00% | – |
| Q1 2021 | $434,000 | – | 59,239 | +493558.3% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 12 | -97.7% | 0.00% | – |
| Q1 2019 | $4,000 | -99.4% | 519 | -99.3% | 0.00% | – |
| Q3 2018 | $652,000 | +67.2% | 73,878 | +61.4% | 0.00% | – |
| Q2 2018 | $390,000 | +9650.0% | 45,776 | +5143.5% | 0.00% | – |
| Q4 2017 | $4,000 | -92.7% | 873 | -84.0% | 0.00% | – |
| Q3 2017 | $55,000 | – | 5,455 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |